Rik Joos Selected Research

Glucocorticoids

3/2017	Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.
4/2015	Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.
12/2012	Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rik Joos Research Topics

Disease

11	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2021 - 07/2004
3	Body Weight (Weight, Body) 01/2021 - 02/2005
3	Infections 02/2020 - 12/2012
2	Pain (Aches) 01/2021 - 01/2019
2	Arthritis (Polyarthritis) 05/2018 - 12/2012
2	Rheumatoid Arthritis 03/2017 - 04/2015
1	Chronic recurrent multifocal osteomyelitis 10/2022
1	Rheumatic Diseases (Rheumatism) 10/2022
1	Chorea (Rheumatic Chorea) 10/2022
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2022
1	Low Back Pain (Lumbago) 12/2021
1	Diphtheria 02/2020
1	Tetanus 02/2020
1	Bacterial Meningitis 01/2019
1	Meningitis 01/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 05/2018
1	Vasculitis (Vasculitides) 05/2018
1	Tendinopathy (Tendonitis) 05/2018
1	Injection Site Reaction 01/2018
1	Joint Diseases (Joint Disease) 03/2017
1	Synovitis 11/2016
1	Dermatomyositis (Dermatopolymyositis) 02/2016
1	Fever (Fevers) 12/2012
1	Neutropenia 12/2012
1	Psoriatic Arthritis 10/2012
1	Hyperplasia 08/2006

Drug/Important Bio-Agent (IBA)

7	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2004
4	tocilizumab (atlizumab)FDA Link 01/2021 - 12/2012
3	GlucocorticoidsIBA 03/2017 - 12/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022 - 02/2020
2	GadoliniumIBA 12/2021 - 11/2016
2	Abatacept (Orencia)FDA Link 02/2020 - 01/2018
2	Antirheumatic Agents (DMARD)IBA 02/2020 - 03/2017
2	C-Reactive ProteinIBA 01/2018 - 03/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 08/2006
1	CytokinesIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Rituximab (Mabthera)FDA Link 10/2022
1	ametantrone (HAQ)IBA 01/2021
1	Diphtheria-Tetanus VaccineIBA 02/2020
1	VaccinesIBA 02/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	BuffersIBA 01/2019
1	Interferon Type IIBA 01/2019
1	InterferonsIBA 01/2019
1	Isotretinoin (Accutane)FDA LinkGeneric 05/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2018
1	golimumab FDA Link 01/2018
1	canakinumab FDA Link 01/2017
1	Prednisone (Sone)FDA LinkGeneric 02/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016
1	Transaminases (Aminotransferases)IBA 12/2012
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2012
1	apremilastIBA 10/2012
1	Infliximab (Remicade)FDA Link 09/2007
1	Chitinase-3-Like Protein 1IBA 08/2006
1	SuspensionsIBA 02/2005
1	Meloxicam (Mobic)FDA LinkGeneric 02/2005
1	Naproxen (Naprosyn)FDA LinkGeneric 02/2005

Therapy/Procedure

4	Therapeutics 10/2022 - 02/2005
1	Injections 01/2018
1	Remission Induction 03/2017
1	Time-to-Treatment 02/2016